Liver disease/transplant. HSR/Epi. Telehealth, behavioral nudges, QI; cognition, aging, @penngihep @PennMedicine, @PennCHIBE, @PennLDI. Wife, mom, academic.
Philadelphia, PA
Joined September 2012
- Tweets2.2K
- Following888
- Followers2.3K
- Likes5.5K
Marina Serper, MD, MS retweeted
The PAL-Liver Trial is out in JAMA Internal Medicine
Headline: Palliative care provided by hepatologists is equivalent to PC specialists
Method: cluster RCT of 935 patients with cirrhosis
Heartbreak: neither arm improved QOL.
Messages (next slide please)
Marina Serper, MD, MS retweeted
Congratulations to LDI Fellow Marina Serper (@serperm) whose study on strategies for managing cirrhosis pain without drugs has been approved for research funding by the Patient-Centered Outcomes Research Institute (@PCORI).
PCORI announced funding awards for new patient-centered CER studies addressing a range of health concerns.
◽11 new patient-centered CER studies addressing a range of pediatric and adult health challenges
◽8 studies advancing CER methods, including strategies for meaningful patient and stakeholder engagement
◽1 project supporting the implementation of PCORI-funded CER findings into real-world clinical settings pcori.me/4pJCgzU
Marina Serper, MD, MS retweeted
So incredibly delighted to be joining the @penngihep family for GI fellowship!!! Wouldn’t be here without my amazing family, friends, and mentors. A dream come true to continue to grow and learn from the greats! @PennMedicine
Congratulations to our incredibly talented class of fellows. We are excited to welcome you to our family?@penngihep
Marina Serper, MD, MS retweeted
Absolutely fantastic Starzl lecture by Dr. Marina Serper of @penngihep at #TLM2025!
Marina Serper, MD, MS retweeted
Award for poster I love hate the most
1. Great epidemiology
2. Too much #cirrhosis in this world
#tlm25 @nadimmahmud
Marina Serper, MD, MS retweeted
Albumin after paracentesis for ascites in cirrhosis is good
One of the few remaining indications
Congratulate Dr Schechter when you see him
#tlm25
Marina Serper, MD, MS retweeted
A dream come true
The LiveSMART trial was able to significantly, substantially reduce falls for patients with cirrhosis and portal hypertension
With thanks to Marina Serper, the team, and the patients who inspired us (and co-designed the trial)
#tlm25
Marina Serper, MD, MS retweeted
Inspiring morning hearing @serperm deliver the @AASLDtweets Starzl Transplant Surgery State of the Art lecture, followed by the @penngihep fellow/faculty brunch catching up with some of her mentees
Marina Serper, MD, MS retweeted
@ebtapper @serperm et al. w/ #TLM25 LB innovative LIVE-SMART program to prevent falls.
Therapeutic interventions: lactulose & tele tai-chi (need WiFi)
NNT for rx sequence 5
Falls matter and we don’t take enough ownership of the problem.
#livertwitter
Marina Serper, MD, MS retweeted
On the way home, The Tappers listened to Nik Mazumder, Juan Carlos Velez, and THE @serperm on this episode of @COREIMpodcast on hepatorenal syndrome
podcasts.apple.com/us/podcas…
Marina Serper, MD, MS retweeted
I think this would be a great session. If not at TLM then elsewhere
In all seriousness, there is a lot of weird stuff that gets done in the name of hepatology.
Marina Serper, MD, MS retweeted
I meant:
-“Correcting” coagulopathy
- Albumin for days for undifferentiated AKI
- Midodrine in a normotensive HRS-AKI pt
- Quinolones in low protein ascites. Never SBP
- UDCA for “treatment” of itching or cholestasis
And yes…steroids for severe AAH chasing trivial benefit
Marina Serper, MD, MS retweeted
🏠New concept: Hepatology@Home
Delivering expert care to complex patients in the community: Ascitic taps, LVP, antibiotics, diuretics.
✅Feasible ✅Safe ✅Avoids admission
It's been v inspiring to watch @TamCarg grow this service from nothing👏
@ebtapper @serperm @NnekaUfereMD
Hep@home: management of patients with liver disease at home @FrontGastro_BMJ @UKHaHSoc @DanLasserson @BryonyRChapman @Dr_Sam_Mills @SophieMcGlen @esaunsbury fg.bmj.com/content/early/202…
Marina Serper, MD, MS retweeted
Thank you @AASLDFoundation and #AnnaLok for supporting my transition from fellowship to faculty. This award will be essential in my journey to become a physician-scientist!
👏 Congratulations to Pedro Ochoa-Allemant of the University of Pennsylvania for receiving the 2025 #AASLDFoundation Anna S. Lok Advanced/Transplant #Hepatology Fellow Award!
Marina Serper, MD, MS retweeted
Check out new research by LDI Fellow Marina Serper (@serperM) on outcomes across steatotic liver disease subtypes. ⤵️
Patients with metabolic dysfunction and alcohol-associated liver disease and alcohol-associated liver disease have modestly higher risks of major adverse liver outcomes and all-cause mortality compared to those with MASLD. ja.ma/44fLBHh
Marina Serper, MD, MS retweeted
Incredible innovations will bring more organ transplants to more people and those organs will be able to travel further and function better. Congratulations to Drs Shaver, Bacchetta, Griesemer and Zuckermann. @ttsorg @VUMChealth
thelancet.com/journals/lance…
Marina Serper, MD, MS retweeted
Advances in precision immunosuppression will protect transplant recipients from immunosuppression’s toxicities. When the organ does suffer injury, new deep phenotyping tools will tell us why. Congratulations to Alex Loupy, Marta Sablik and Kiran Khush. thelancet.com/journals/lance…
